MR Imaging in Real Time Guiding of Therapies in Prostate Cancer
Viitala et al, BJU Int (2025)
Read the publication
Treat a wider spectrum of prostate cancer and BPH patients—and help them maintain their quality of life.
Proven In
4000+
Procedures
The TULSA-PRO Difference
TULSA-PRO® is the only MRI-guided, incision-free prostate therapy that delivers unmatched flexibility and precision—enabling surgeons to treat prostate disease, and utilize any treatment plan with confidence.
One platform. Multiple treatment strategies
TULSA-PRO enables focal, multifocal, hemi, partial, subtotal, and whole-gland ablation—and everything in between—on a single system.
No trade-offs between precision and coverage
Treats anterior, posterior, apical, peripheral, or central lesions.
Real-time MRI for real-time decision making.
Treatment is planned and adjusted live with evolving boundaries to account for edema and tissue changes—not possible with ultrasound-based systems.
A mainstream, future-ready technology
One system that adapts to patient heterogeneity rather than forcing patient selection to fit the technology.
Discover the Future of Prostate Surgery
Treatment Built on Three Clinical Pillars
Confidence
- Real-time MRI visualization and thermometry before, during, and after treatment
- Closed-loop temperature feedback control for predictable ablation
- CAPTAIN randomized trial demonstrates perioperative advantages vs. prostatectomy
Precision
- Directional ultrasound with millimeter-level control
- AI-assisted contouring and treatment planning
- Pixel-by-pixel thermal dosing guided by MRI thermography
Preservation
- Designed to prioritize continence and sexual function
- No incision, no radiation, no procedural blood loss
- Single-session outpatient procedure
Suitable for a Wide Range of Prostate Cancer and BPH Patients
Benign
BPH, any size or shape
Organ Confined Prostate Cancer
Combination prostate cancer & BPH
Lesion targeted focal ablation
Whole-gland customized for Quality of life
Salvage
Second line treatment after failed local therapy
Locally Advanced
Palliative debulking & symptom relief
In Use by Clinicians at Many of North America's Leading Medical Centers
TULSA-PRO patients are in better overall health after treatment compared to RP
Significantly Better Overall health During First Month Post-Treatment
Meng et al. MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION (TULSA) OF LOCALIZED PROSTATE CANCER: SINGLE INSTITUTION EXPERIENCE OF TREATMENT EFFICACY. The Journal of Urology (2025)
Backed by 70+ peer-reviewed publications, including:
Salvage transurethral ultrasound ablation (TULSA) for localized radio-recurrent prostate cancer: 12-month safety and oncological outcomes
Anttinen et al, The Journal of Urology (2024)
Read the publicationPivotal Study of MRI Guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: 5-Year Follow Up
Eggener, Scott, et al, Journal of Urologic Oncology (2023)
Read the publicationMagnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer: A Systematic Review
Dora et al, Journal of Endourology (2022)
Read the publicationMagnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
Klotz et al, The Journal of Urology (2021)
Read the publicationA brief overview of how TULSA-PRO works
Hear from your colleagues on PRO-TALK
Access an educational platform created for physicians by physicians that connects you with webinars, thought leaders, and other experts to uncover new trends, advancements in medical technologies, and research relating to prostate health.
Get Access